Switching Meds-Can I go back if it doesnt work?
Jul 19, 2012
Hello Drs. I've been HIV+ close to 2 1/2 years and have been on Prezista/truvada/norvir combo. I'm undetectable and my cd4 counts is currently above 750. I'm doing very well on my current regimen and recently saw my specialist and mentioned I'd be interested in trying complera as it is just one pill a day as opposed to my four with my current regimen. She agreed to switch me over and also she said if this doesn't work out I could try the quad pill when it comes out later this year. My concern is that if I don't tolerate either pill well would it be possible to go back to my current meds? Best Regards.
Response from Dr. Young
Hello and thanks for posting.
So long as the current regimen is your first regimen and there's no historical or current concerns about drug resistant HIV, then switching from your current regimen to Complera (or the soon to be FDA approved Quad) should be fine.
Similarly, if things don't work out after switching, you could switch back to your current regimen (at least until a better tolerated option was available for you).
Hope that helps, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- What Does Chlamydia Discharge Look Like?
- What Color Are Herpes Lesions?
- What Can't You Do With Herpes?
- What Are The Odds Of Contracting Genital Herpes After Sleeping With Someone Who Has It But Not An Outbreak?
- Treatment Of Male Partner Bacterial Vaginosis
- Is Tea Tree Oil Used To Treat Gonorrhea?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.